Mole Checker & Skin AI: Galow is a dermatological wellness app for iOS that uses AI to analyze skin lesions and generate personalized skincare routines.
The App DNA
What makes this app unique?
Users want a low-friction way to monitor skin changes and ingredient safety without the immediate cost of a clinical consultation.
For Individuals interested in dermatological health monitoring, personalized skincare routines, and seasonal color theory.
What does it look like?
Key features
Evaluates skin lesions using ABCD criteria via AI image analysis to provide risk estimates.
Monitors hydration, texture, and acne levels over time using selfie analysis to drive retention.
Generates daily regimens based on skin type analysis to create habit loops.
How much does it cost?
Subscription model gates advanced features behind weekly and yearly Pro tiers.
Velocity
Maintenance developmentopaqueShow more...
The app has shipped only one release in the last 99 days, placing it firmly in a maintenance state. There is no evidence of active development or recurring feature updates following the initial launch. The lack of subsequent version history suggests a period of stagnation rather than an active development cycle.
Who built it?
Muhammet Talha VAROL
6 apps tracked · Lifestyle
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Mole Checker & Skin AI: Galow
How's the Lifestyle market?
Mole Checker & Skin AI: Galow operates in the niche lifestyle-dermatology space, currently maintaining a 17+ content rating on iOS. The lack of updates since the May 2026 launch suggests a static market position that may struggle to retain users against more active competitors.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Mole Checker & Skin AI: Galow
Where is it heading?
The dermatological wellness market is consolidating around apps that offer both monitoring and clear clinical pathways. Mole Checker & Skin AI: Galow remains exposed due to its lack of development cadence, which will likely lead to churn as users seek more reliable, frequently updated health tools.
- The 100-day development silence since the initial release suggests a lack of active maintenance, which erodes user trust in health-monitoring tools.
- The ABCD-based mole evaluation remains a strong, differentiated mechanism that provides clear value if the app returns to an active release cadence.
The SWOT
- ABCD-based AI analysis provides a specific, defensible mechanism for initial lesion monitoring.
- Telehealth referral integration could bridge the gap between wellness monitoring and clinical diagnosis.
Next best moves
Ship a content-update sprint because the app has been dormant for over 100 days → restore user trust
The counter-intuitive read
The lack of updates is the primary risk: in the health-wellness category…
Read the full takeSince the last report: The app's feature set expanded to include ingredient analysis, while the SWOT analysis pivoted to address regulatory risks and clinical referral opportunities. Development remains stagnant with no updates since the initial release.
Bottom line
Mole Checker & Skin AI: Galow provides a clear, mechanism-based utility for skin monitoring, but the lack of development cadence since launch risks user abandonment as the competitive landscape shifts toward more active, data-integrated platforms.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated